These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7754546)

  • 1. Distribution of the carbohydrate antigens, DU-PAN-2 and CA19-9, in tumors of the lung.
    Ohshio G; Yamaki K; Imamura T; Suwa H; Chang CY; Wada H; Sueno Y; Imamura M
    Tumori; 1995; 81(1):67-73. PubMed ID: 7754546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical studies on the localization of cancer associated antigens DU-PAN-2 and CA19-9 in carcinomas of the digestive tract.
    Ohshio G; Ogawa K; Kudo H; Yamabe H; Nakashima Y; Kim YC; Endo K; Watanabe Y; Manabe T; Tobe T
    J Gastroenterol Hepatol; 1990; 5(1):25-31. PubMed ID: 2103381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical localization of CEA, CA19-9 and DU-PAN-2 in hepatitis C virus-infected liver tissues.
    Kitagawa Y; Iwai M; Muramatsu A; Tanaka S; Mori T; Harada Y; Okanoue T; Kashima K
    Histopathology; 2002 May; 40(5):472-9. PubMed ID: 12010368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of carbohydrate antigens (SSEA-1, sialyl-Lewis X, DU-PAN-2 and CA19-9) and E-selectin in urothelial carcinoma of the renal pelvis, ureter, and urinary bladder.
    Kajiwara H; Yasuda M; Kumaki N; Shibayama T; Osamura Y
    Tokai J Exp Clin Med; 2005 Sep; 30(3):177-82. PubMed ID: 16285609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical heterogeneity of type 1 blood group antigen expressions in testicular germ cell tumors.
    Kamoshida S; Satoh Y; Yasuda M; Kajiwara H; Tsukinoki K; Osamura RY
    Oncol Rep; 2002; 9(4):845-51. PubMed ID: 12066220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum carbohydrate antigen elevations in endometrial adenocarcinomas: characterization of DU-PAN-2 expression as a tumor marker.
    Yasuda M; Saito K; Kobayashi Y; Muramatsu T; Miyamoto T; Murakami M; Shinozuka T; Ishizuka B; Makino T; Kajiwara H; Osamura RY
    J Obstet Gynaecol Res; 2004 Feb; 30(1):59-64. PubMed ID: 14718023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas.
    Kamoshida S; Ogane N; Yasuda M; Muramatsu T; Bessho T; Kajiwara H; Osamura RY
    Mod Pathol; 2000 Jul; 13(7):736-41. PubMed ID: 10912932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals.
    Attanoos RL; Thomas DH; Gibbs AR
    Histopathology; 2003 Oct; 43(4):387-92. PubMed ID: 14511258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CA19-9, DU-PAN-2, and SPan-1 antigens on two types of normal salivary mucins.
    Ho JJ; Norton K; Chung YS; Kim YS
    Oncol Res; 1993; 5(9):347-56. PubMed ID: 7518709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progenitor stem cell marker expression by pulmonary carcinomas.
    Moreira AL; Gonen M; Rekhtman N; Downey RJ
    Mod Pathol; 2010 Jun; 23(6):889-95. PubMed ID: 20305619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of tumor marker levels in cystic fluid of benign liver cysts.
    Iwase K; Takenaka H; Oshima S; Yagura A; Nishimura Y; Yoshidome K; Tanaka T
    Dig Dis Sci; 1992 Nov; 37(11):1648-54. PubMed ID: 1385056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice.
    Ohshio G; Manabe T; Watanabe Y; Endo K; Kudo H; Suzuki T; Tobe T
    Am J Gastroenterol; 1990 Oct; 85(10):1370-6. PubMed ID: 2220731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-MOC-31: a potential addition to the pulmonary adenocarcinoma versus mesothelioma immunohistochemistry panel.
    Sosolik RC; McGaughy VR; De Young BR
    Mod Pathol; 1997 Jul; 10(7):716-9. PubMed ID: 9237183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients.
    Narimatsu H; Iwasaki H; Nakayama F; Ikehara Y; Kudo T; Nishihara S; Sugano K; Okura H; Fujita S; Hirohashi S
    Cancer Res; 1998 Feb; 58(3):512-8. PubMed ID: 9458099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites.
    Mitselou A; Batistatou A; Nakanishi Y; Hirohashi S; Vougiouklakis T; Charalabopoulos K
    Histol Histopathol; 2010 Oct; 25(10):1257-67. PubMed ID: 20712010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DU-PAN-2 levels in serum and pancreatic ductal fluids of patients with benign and malignant pancreatic disease.
    Mahvi DM; Seigler HF; Meyers WC; Kalthoff H; Schmiegel WH; Metzgar RS
    Pancreas; 1988; 3(4):488-93. PubMed ID: 3174610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies on expression of CA 19-9 and DU-PAN-2 in pancreatic cancer tissue.
    Takasaki H; Uchida E; Tempero MA; Burnett DA; Metzgar RS; Pour PM
    Int J Pancreatol; 1987; 2(5-6):349-60. PubMed ID: 3320227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical study on the expression of carbohydrate antigens in normal squamous epithelia and squamous cell carcinomas of the uterine cervix].
    Tsukada S
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Feb; 46(2):137-44. PubMed ID: 7907353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical phenotype of malignant mesothelioma: predictive value of CA125 and HBME-1 expression.
    Bateman AC; al-Talib RK; Newman T; Williams JH; Herbert A
    Histopathology; 1997 Jan; 30(1):49-56. PubMed ID: 9023557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis.
    Carella R; Deleonardi G; D'Errico A; Salerno A; Egarter-Vigl E; Seebacher C; Donazzan G; Grigioni WF
    Am J Surg Pathol; 2001 Jan; 25(1):43-50. PubMed ID: 11145250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.